Current ACMG Guidelines recommend microarray as a 1st line test for constitutional genetic abnormalities. As a result, high-density SNP and aCGH arrays are the most common platforms for cytogenetic analyses. Unfortunately, the standard microarray designs being used for cytogenetic analysis today were designed years ago and thus do not represent current clinically relevant knowledge.
Register to read more about the latest Illumina’s Infinium Global Diversity Array with Cytogenetics (GDACyto) and Infinium Global Screening Array with Cytogenetics (GSACyto) coupled with BioDiscovery’s N Clinical analysis software.
